Jpmorgan Chase & CO Cardlytics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Cardlytics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 18,684 shares of CDLX stock, worth $49,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,684
Previous 18,082
3.33%
Holding current value
$49,138
Previous $57,000
21.05%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CDLX
# of Institutions
122Shares Held
30.4MCall Options Held
509KPut Options Held
263K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$16.8 Million1.38% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$8.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$7.08 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.31MShares$3.45 Million0.35% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$3.21 Million0.92% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $86.5M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...